Assessment of minimal residual disease in standard-risk AML

UK National Cancer Research Institute AML Working Group

Research output: Contribution to journalArticlepeer-review

404 Citations (Scopus)
586 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Assessment of minimal residual disease in standard-risk AML'. Together they form a unique fingerprint.

Medicine & Life Sciences